United States · FDA National Drug Code directory
XeroBurn Burn Gel
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67777-129_303feeb7-93b4-5920-e063-6394a90a0caf
- Product NDC
- 67777-129
- Form
- GEL
- Composition / generic term
- Lidocaine Hydrochloride
- Labeler
- Dynarex Corporation
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20170907
- Source listing expiry
- 20261231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE — 2 g/100g
These values do not establish equivalence or a dose recommendation.
Packages
- 1728 PACKET in 1 CASE (67777-129-02) / 3.5 g in 1 PACKET · 67777-129-02
- 600 BOX in 1 CASE (67777-129-09) / 25 PACKET in 1 BOX (67777-129-00) / 3.5 g in 1 PACKET · 67777-129-09
- 600 BOX in 1 CASE (67777-129-10) / 6 PACKET in 1 BOX (67777-129-01) / 3.5 g in 1 PACKET · 67777-129-10
- 24 BOTTLE in 1 CASE (67777-129-11) / 113 g in 1 BOTTLE (67777-129-03) · 67777-129-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →